RU95107880A - SOLID PHARMACEUTICAL FORM - Google Patents
SOLID PHARMACEUTICAL FORMInfo
- Publication number
- RU95107880A RU95107880A RU95107880/14A RU95107880A RU95107880A RU 95107880 A RU95107880 A RU 95107880A RU 95107880/14 A RU95107880/14 A RU 95107880/14A RU 95107880 A RU95107880 A RU 95107880A RU 95107880 A RU95107880 A RU 95107880A
- Authority
- RU
- Russia
- Prior art keywords
- dosage form
- pharmaceutical dosage
- amylose
- crosslinking
- enzyme
- Prior art date
Links
- 239000007787 solid Substances 0.000 title claims 2
- 239000002552 dosage form Substances 0.000 claims 7
- 229920000856 Amylose Polymers 0.000 claims 4
- 229940088598 Enzyme Drugs 0.000 claims 3
- 102000004190 Enzymes Human genes 0.000 claims 3
- 108090000790 Enzymes Proteins 0.000 claims 3
- 150000001875 compounds Chemical class 0.000 claims 3
- 238000004132 cross linking Methods 0.000 claims 3
- BRLQWZUYTZBJKN-UHFFFAOYSA-N epichlorohydrin Chemical compound ClCC1CO1 BRLQWZUYTZBJKN-UHFFFAOYSA-N 0.000 claims 3
- 229920000642 polymer Polymers 0.000 claims 3
- 239000003431 cross linking reagent Substances 0.000 claims 2
- QWVCIORZLNBIIC-UHFFFAOYSA-N 2,3-dibromopropan-1-ol Chemical compound OCC(Br)CBr QWVCIORZLNBIIC-UHFFFAOYSA-N 0.000 claims 1
- 102000004139 alpha-Amylases Human genes 0.000 claims 1
- 108090000637 alpha-Amylases Proteins 0.000 claims 1
- 229940024171 alpha-amylase Drugs 0.000 claims 1
- 230000024881 catalytic activity Effects 0.000 claims 1
- 238000007907 direct compression Methods 0.000 claims 1
- 239000003814 drug Substances 0.000 claims 1
- 229940079593 drugs Drugs 0.000 claims 1
- 239000000203 mixture Substances 0.000 claims 1
- 230000000051 modifying Effects 0.000 claims 1
Claims (5)
Applications Claiming Priority (3)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US91976292A | 1992-07-24 | 1992-07-24 | |
US919,762 | 1992-07-24 | ||
PCT/CA1993/000298 WO1994002121A1 (en) | 1992-07-24 | 1993-07-22 | Cross-linked polyhydroxylic material for enzymatically controlled drug release |
Publications (2)
Publication Number | Publication Date |
---|---|
RU95107880A true RU95107880A (en) | 1997-11-10 |
RU2136270C1 RU2136270C1 (en) | 1999-09-10 |
Family
ID=25442612
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
RU95107880/14A RU2136270C1 (en) | 1992-07-24 | 1993-07-22 | Solid pharmaceutical form |
Country Status (18)
Country | Link |
---|---|
EP (1) | EP0651634B1 (en) |
JP (1) | JP3647859B2 (en) |
KR (1) | KR100304997B1 (en) |
AT (1) | ATE137668T1 (en) |
AU (1) | AU668198B2 (en) |
CA (1) | CA2140032C (en) |
CZ (1) | CZ283395B6 (en) |
DE (1) | DE69302580T2 (en) |
ES (1) | ES2086949T3 (en) |
FI (1) | FI950301A0 (en) |
GR (1) | GR3020476T3 (en) |
HU (1) | HU221591B (en) |
MX (1) | MX9304459A (en) |
NO (1) | NO308024B1 (en) |
NZ (1) | NZ254048A (en) |
PL (1) | PL173249B1 (en) |
RU (1) | RU2136270C1 (en) |
WO (1) | WO1994002121A1 (en) |
Families Citing this family (14)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CA2173818A1 (en) * | 1996-04-10 | 1997-10-11 | Francois Chouinard | Time-released pharmaceutical compound containing a cured amylose-based support and hydroxypropylmethylcellulose |
DE19640062B4 (en) | 1996-09-28 | 2006-04-27 | Lts Lohmann Therapie-Systeme Ag | Oral preparation comprising in a matrix swellable in an aqueous medium at least one pharmaceutical active substance |
US5879707A (en) * | 1996-10-30 | 1999-03-09 | Universite De Montreal | Substituted amylose as a matrix for sustained drug release |
US5807575A (en) * | 1997-02-14 | 1998-09-15 | Rougier Inc. | Manufacture of cross-linked amylose useful as a excipient for control release of active compounds |
AU7501398A (en) * | 1997-05-21 | 1998-12-11 | Warner-Lambert Company | Non-sedating acrivastine preparation |
CA2217238C (en) * | 1997-10-24 | 2005-09-20 | Louis Cartilier | Cross-linked cellulose as a tablet excipient |
HUP0301333A3 (en) | 1999-12-06 | 2005-06-28 | Penwest Pharmaceuticals Co Sea | Pharmaceutical superdisintegrant, process for its preparation and its use |
US6607748B1 (en) | 2000-06-29 | 2003-08-19 | Vincent Lenaerts | Cross-linked high amylose starch for use in controlled-release pharmaceutical formulations and processes for its manufacture |
TWI319713B (en) | 2002-10-25 | 2010-01-21 | Sustained-release tramadol formulations with 24-hour efficacy | |
US8487002B2 (en) | 2002-10-25 | 2013-07-16 | Paladin Labs Inc. | Controlled-release compositions |
ES2389666T3 (en) | 2005-09-09 | 2012-10-30 | Angelini Labopharm, Llc | Trazodone composition for once-daily administration |
CN101304764B (en) | 2005-11-11 | 2012-12-05 | 旭化成化学株式会社 | Solid formulation to control-release |
AR082189A1 (en) | 2010-07-06 | 2012-11-21 | Gruenenthal Gmbh | GASTRORTENTIVE DOSAGE FORMS, PROCEDURE |
US20120015031A1 (en) | 2010-07-14 | 2012-01-19 | Grunenthal Gmbh | Novel gastro-retentive dosage forms |
Family Cites Families (4)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
US3181998A (en) * | 1960-08-12 | 1965-05-04 | Joseph L Kanig | Tablet disintegration |
US3493652A (en) * | 1962-09-14 | 1970-02-03 | Charles W Hartman | Controlled release medicament |
SE420565B (en) * | 1974-06-06 | 1981-10-19 | Pharmacia Ab | AID FOR INTRAVASCULAR ADMINISTRATION FOR USE IN CONNECTION WITH INTRAVASCULAR ADMINISTRATION OF A SOLUTION OR SUSPENSION OF A DIAGNOSTIC AGENT |
DE3721574A1 (en) * | 1987-06-30 | 1989-01-12 | Kettelhack Riker Pharma Gmbh | MEDICINAL PRODUCTS IN THE FORM OF PELLETS WITH ENZYMATICALLY CONTROLLED DRUG RELEASE |
-
1993
- 1993-07-22 AT AT93915611T patent/ATE137668T1/en not_active IP Right Cessation
- 1993-07-22 ES ES93915611T patent/ES2086949T3/en not_active Expired - Lifetime
- 1993-07-22 CA CA002140032A patent/CA2140032C/en not_active Expired - Lifetime
- 1993-07-22 AU AU45559/93A patent/AU668198B2/en not_active Expired
- 1993-07-22 EP EP93915611A patent/EP0651634B1/en not_active Expired - Lifetime
- 1993-07-22 HU HU9500197A patent/HU221591B/en unknown
- 1993-07-22 JP JP50404894A patent/JP3647859B2/en not_active Expired - Fee Related
- 1993-07-22 WO PCT/CA1993/000298 patent/WO1994002121A1/en active IP Right Grant
- 1993-07-22 KR KR1019950700243A patent/KR100304997B1/en not_active IP Right Cessation
- 1993-07-22 PL PL93307234A patent/PL173249B1/en unknown
- 1993-07-22 NZ NZ254048A patent/NZ254048A/en not_active IP Right Cessation
- 1993-07-22 CZ CZ95152A patent/CZ283395B6/en not_active IP Right Cessation
- 1993-07-22 RU RU95107880/14A patent/RU2136270C1/en active IP Right Revival
- 1993-07-22 DE DE69302580T patent/DE69302580T2/en not_active Expired - Lifetime
- 1993-07-23 MX MX9304459A patent/MX9304459A/en unknown
-
1995
- 1995-01-23 NO NO950251A patent/NO308024B1/en not_active IP Right Cessation
- 1995-01-24 FI FI950301A patent/FI950301A0/en unknown
-
1996
- 1996-07-09 GR GR960401844T patent/GR3020476T3/en unknown
Similar Documents
Publication | Publication Date | Title |
---|---|---|
RU95107880A (en) | SOLID PHARMACEUTICAL FORM | |
CA2041774A1 (en) | Use of cross-linked amylose as a matrix for the slow release of biologically active compounds | |
US4482534A (en) | Nitroglycerin preparations | |
ES8402155A1 (en) | Prolonged release therapeutic compositions based on hydroxypropylmethylcellulose | |
CA2208322A1 (en) | Directly compressible high load acetaminophen formulations | |
KR950007841A (en) | Sustained-release drug formulations containing tramadol salts | |
JPH0840879A (en) | Expandable medicine configuration | |
CA2084680A1 (en) | Process for the manufacture of porous cellulose matrices | |
PT723777E (en) | COMPRESSED CONTAINING ENTERIC GRANULOS | |
ATE100708T1 (en) | UNCOATED PHARMACEUTICAL REACTION TABLET. | |
ATE246505T1 (en) | PREPARATION CONTAINING CEFACLOR OR CEPHALEXIN WITH MODIFIED RELEASE MATRIX | |
CA2354057A1 (en) | Sustained release tablet containing hydrocolloid and cellulose ether | |
NO813826L (en) | Pain-degrading drug presses | |
EP0139127A1 (en) | Transdermal drug delivery device and its preparation | |
AU2793989A (en) | Method for preparing a solid sustained release form of a functionally active composition and the dosage form so obtained | |
ZA869586B (en) | Pharmaceutical product for the sustained release of ibuprofen | |
CA2383212A1 (en) | Controlled release oral dosage suitable for oral administration | |
PT975348E (en) | STABILIZED TIBOLONE COMPOSITIONS | |
RU2002123182A (en) | CONTAINING IBUPROFEN COMPOSITION | |
HU9500197D0 (en) | Gross-linked polyhydroxylic material for enzymatically controlled drug release | |
JPS63270624A (en) | Production of stabilized nicorandil pharmaceutical | |
RU94026856A (en) | Nootropic and tranquilizing agent | |
RU92004569A (en) | PHARMACEUTICAL PRODUCT OF ANTI-STRESS, STRESS-PROTECTIVE AND NOOTROPIC ACTION | |
RU95121646A (en) | Crosslinked amylose as a binder / agent that causes disintegration in tablets | |
CA2217238A1 (en) | Cross-linked cellulose as a tablet excipient |